Side effects and antibody titer transition of the BNT162b2 messenger ribonucleic acid coronavirus disease 2019 vaccine in Japan
Takehiro Izumo, Naoyuki Kuse, Nobuyasu Awano, Mari Tone, Keita Sakamoto, Kohei Takada, Yutaka Muto, Kazushi Fujimoto, Ayae Saiki, Yu Ito, Haruko Matsumoto, Minoru Inomata
Topics & Concepts
MedicineTiterVaccinationCoronavirus disease 2019 (COVID-19)AntibodyAntibody titerIncidence (geometry)Internal medicineAntibody responseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Side effect (computer science)ImmunologyDiseaseInfectious disease (medical specialty)Programming languagePhysicsComputer scienceOpticsSARS-CoV-2 and COVID-19 ResearchLong-Term Effects of COVID-19COVID-19 Clinical Research Studies